CHAPMAN GLOBAL MEDICAL CENTER — History
CCN 050745 | 3-year financial timeline | COVID resilience: 50/100
🛡️ Public data only — no PHI permitted on this instance.
$21M
Latest Revenue (FY2022)
-32.9%
Revenue CAGR (3yr)
1.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $47M | $54M | $21M | -61.1% | -32.9% |
| Operating Expenses | $54M | $55M | $21M | -62.2% | -37.9% |
| Operating Margin | -15.1% | -1.4% | 1.4% | +202.5% | +0.0% |
| Net Income | $-7M | $-1M | $0M | +139.9% | +0.0% |
| Licensed Beds | 75 | 75 | 75 | +0.0% | +0.0% |
| Total Patient Days | 7,483 | 7,062 | 2,507 | -64.5% | -42.1% |
| Medicare Day % | 25% | 26% | 29% | +8.7% | +7.4% |
| Medicaid Day % | 11% | 9% | 9% | -5.7% | -9.5% |
COVID Impact & Recovery
Resilience Score: 50/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: -55.0% ($47M → $21M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
-32.9%
This Hospital
+7.6%
State Avg
Latest Margin
1.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $8M | 9.7% |
| FY2024 (proj) | $-5M | 18.0% |
| FY2025 (proj) | $-18M | 26.3% |